[HTML][HTML] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards, HL Tanner… - The Lancet …, 2020 - thelancet.com
The COVID-19 pandemic continues to wreak havoc on global health-care systems and to
claim an increasing number of lives. Although some treatments have shown promise …
claim an increasing number of lives. Although some treatments have shown promise …
[HTML][HTML] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards, HL Tanner… - The Lancet …, 2020 - thelancet.com
The COVID19 pandemic continues to wreak havoc on global healthcare systems and to
claim an increasing number of lives. Although some treatments have shown promise …
claim an increasing number of lives. Although some treatments have shown promise …
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment.
PC Robinson, D Richards, HL Tanner… - The Lancet …, 2020 - europepmc.org
The COVID-19 pandemic continues to wreak havoc on global health-care systems and to
claim an increasing number of lives. Although some treatments have shown promise …
claim an increasing number of lives. Although some treatments have shown promise …
[引用][C] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19
treatment Accumulating evidence suggests anti-TNF therapy needs to be given trial priority …
treatment Accumulating evidence suggests anti-TNF therapy needs to be given trial priority …
[引用][C] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards, HL Tanner… - The Lancet …, 2020 - cir.nii.ac.jp
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19
treatment | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
treatment | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[PDF][PDF] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards, HL Tanner… - Lancet …, 2020 - ora.ox.ac.uk
1 Accumulating evidence suggests anti-tumour necrosis factor therapy needs to be given trial
priority in COVID-19 treatment Phil Page 1 1 Accumulating evidence suggests anti-tumour …
priority in COVID-19 treatment Phil Page 1 1 Accumulating evidence suggests anti-tumour …
[HTML][HTML] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards, HL Tanner… - The Lancet …, 2020 - ncbi.nlm.nih.gov
The COVID19 pandemic continues to wreak havoc on global healthcare systems and to
claim an increasing number of lives. Although some treatments have shown promise …
claim an increasing number of lives. Although some treatments have shown promise …
[引用][C] Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
PC Robinson, D Richards… - The Lancet …, 2020 - espace.library.uq.edu.au
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment.
PC Robinson, D Richards, HL Tanner… - The Lancet …, 2020 - europepmc.org
The COVID19 pandemic continues to wreak havoc on global healthcare systems and to
claim an increasing number of lives. Although some treatments have shown promise …
claim an increasing number of lives. Although some treatments have shown promise …